173 related articles for article (PubMed ID: 34605323)
21. Simultaneous assessment of regional distributions of atrophy across the neuraxis in MS patients.
Freund P; Papinutto N; Bischof A; Azzarito M; Kirkish G; Ashburner J; Thompson A; Hauser SL; Henry RG
Neuroimage Clin; 2022; 34():102985. PubMed ID: 35316667
[TBL] [Abstract][Full Text] [Related]
22. Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis.
Storelli L; Pagani E; Meani A; Preziosa P; Filippi M; Rocca MA
J Neurol; 2022 Sep; 269(9):4729-4741. PubMed ID: 35397753
[TBL] [Abstract][Full Text] [Related]
23. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
[TBL] [Abstract][Full Text] [Related]
24. The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis.
Zurawski J; Glanz BI; Healy BC; Tauhid S; Khalid F; Chitnis T; Weiner HL; Bakshi R
J Neurol Sci; 2019 Aug; 403():38-43. PubMed ID: 31207364
[TBL] [Abstract][Full Text] [Related]
25. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
[TBL] [Abstract][Full Text] [Related]
26. Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes.
Bernitsas E; Bao F; Seraji-Bozorgzad N; Chorostecki J; Santiago C; Tselis A; Caon C; Zak I; Millis S; Khan O
Mult Scler Relat Disord; 2015 Jan; 4(1):47-51. PubMed ID: 25787052
[TBL] [Abstract][Full Text] [Related]
27. Spinal Cord Atrophy in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Casserly C; Seyman EE; Alcaide-Leon P; Guenette M; Lyons C; Sankar S; Svendrovski A; Baral S; Oh J
J Neuroimaging; 2018 Nov; 28(6):556-586. PubMed ID: 30102003
[TBL] [Abstract][Full Text] [Related]
28. Regional cervical cord atrophy and disability in multiple sclerosis: a voxel-based analysis.
Valsasina P; Rocca MA; Horsfield MA; Absinta M; Messina R; Caputo D; Comi G; Filippi M
Radiology; 2013 Mar; 266(3):853-61. PubMed ID: 23192778
[TBL] [Abstract][Full Text] [Related]
29. Relationship between cervical spinal cord morphometry and clinical disability in patients with multiple sclerosis.
Celik NG; Karabulut AK; Fazliogullari Z; Gumus H; Cebeci H; Dogan NU
Rev Assoc Med Bras (1992); 2023; 69(12):e20230949. PubMed ID: 37971136
[TBL] [Abstract][Full Text] [Related]
30. Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy.
Ladopoulos T; Matusche B; Bellenberg B; Heuser F; Gold R; Lukas C; Schneider R
Neuroimage Clin; 2022; 36():103166. PubMed ID: 36081258
[TBL] [Abstract][Full Text] [Related]
31. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
32. Cervical cord lesion load is associated with disability independently from atrophy in MS.
Kearney H; Altmann DR; Samson RS; Yiannakas MC; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
Neurology; 2015 Jan; 84(4):367-73. PubMed ID: 25540312
[TBL] [Abstract][Full Text] [Related]
33. Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira A; Sastre-Garriga J; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Filippi M;
Neurology; 2021 Mar; 96(11):e1561-e1573. PubMed ID: 33441452
[TBL] [Abstract][Full Text] [Related]
34. Diffusion tensor imaging of normal-appearing cervical spinal cords in patients with multiple sclerosis: Correlations with clinical evaluation and cerebral diffusion tensor imaging changes. Preliminary experience.
Wolańczyk M; Bladowska J; Kołtowska A; Pokryszko-Dragan A; Podgórski P; Budrewicz S; Sąsiadek M
Adv Clin Exp Med; 2020 Apr; 29(4):441-448. PubMed ID: 32369275
[TBL] [Abstract][Full Text] [Related]
35. Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.
Bischof A; Papinutto N; Keshavan A; Rajesh A; Kirkish G; Zhang X; Mallott JM; Asteggiano C; Sacco S; Gundel TJ; Zhao C; Stern WA; Caverzasi E; Zhou Y; Gomez R; Ragan NR; Santaniello A; Zhu AH; Juwono J; Bevan CJ; Bove RM; Crabtree E; Gelfand JM; Goodin DS; Graves JS; Green AJ; Oksenberg JR; Waubant E; Wilson MR; Zamvil SS; ; Cree BAC; Hauser SL; Henry RG
Ann Neurol; 2022 Feb; 91(2):268-281. PubMed ID: 34878197
[TBL] [Abstract][Full Text] [Related]
36. Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.
Aymerich FX; Auger C; Alonso J; Alberich M; Sastre-Garriga J; Tintoré M; Montalban X; Rovira A
AJNR Am J Neuroradiol; 2018 Feb; 39(2):399-404. PubMed ID: 29284602
[TBL] [Abstract][Full Text] [Related]
37. Investigating Functional Network Abnormalities and Associations With Disability in Multiple Sclerosis.
Carotenuto A; Valsasina P; Schoonheim MM; Geurts JJG; Barkhof F; Gallo A; Tedeschi G; Tommasin S; Pantano P; Filippi M; Rocca MA;
Neurology; 2022 Nov; 99(22):e2517-e2530. PubMed ID: 36096690
[TBL] [Abstract][Full Text] [Related]
38. Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis.
Lee LE; Vavasour IM; Dvorak A; Liu H; Abel S; Johnson P; Ristow S; Au S; Laule C; Tam R; Li DK; Cross H; Ackermans N; Schabas AJ; Chan J; Sayao AL; Devonshire V; Carruthers R; Traboulsee A; Kolind S
Mult Scler; 2021 Dec; 27(14):2191-2198. PubMed ID: 33749378
[TBL] [Abstract][Full Text] [Related]
39. Preferential spinal cord volume loss in primary progressive multiple sclerosis.
Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K
Mult Scler; 2019 Jun; 25(7):947-957. PubMed ID: 29781383
[TBL] [Abstract][Full Text] [Related]
40. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Hofstetter L; Naegelin Y; Filli L; Kuster P; Traud S; Smieskova R; Mueller-Lenke N; Kappos L; Gass A; Sprenger T; Penner IK; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
Mult Scler; 2014 Feb; 20(2):202-13. PubMed ID: 23804554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]